Structures by: Stanley N.
Total: 9
2-Aminopyridinium 6-chloronicotinate
C5H7N2,C6H3ClNO2
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 9 o655-6
a=8.6844(4)Å b=10.8112(5)Å c=11.9235(6)Å
α=90° β=95.2046(9)° γ=90°
Diaquadinitratothiabendazolecopper(II)
C10H11CuN5O8S
Acta Crystallographica Section E (2002) 58, 8 m392-m395
a=7.580(4)Å b=20.065(5)Å c=10.606(2)Å
α=90° β=109.51(3)° γ=90°
Trimethoprim perchlorate
C14H19N4O31,ClO41
Acta Crystallographica Section E (2002) 58, 1 o59-o61
a=9.672(2)Å b=10.2190(10)Å c=9.651(2)Å
α=91.190(10)° β=107.180(10)° γ=72.44(2)°
Trimethoprim salicylate methanol solvate
C14H19N4O31,C7H5O31,CH4O
Acta Crystallographica Section E (2002) 58, 2 o180-o182
a=10.0139(19)Å b=10.2600(19)Å c=11.984(9)Å
α=105.93(3)° β=109.17(5)° γ=92.50(2)°
Thiabendazolium perchlorate
C10H8N3S1,ClO41
Acta Crystallographica Section E (2002) 58, 4 o426-o428
a=14.121(15)Å b=5.245(2)Å c=17.384(15)Å
α=90° β=108.99(11)° γ=90°
N^6^-benzyladenine hydrobromide
C12H12BrN5
Acta Crystallographica Section E (2001) 57, 9 o881-o883
a=18.581(3)Å b=5.163(2)Å c=13.344(3)Å
α=90° β=93.71(2)° γ=90°
Trimethoprim sulfate trihydrate
2C14H19N4O31,SO41,3H2O
Acta Crystallographica Section E (2001) 57, 12 o1179-o1182
a=7.2290(10)Å b=23.2420(10)Å c=20.3730(10)Å
α=90° β=98.590(10)° γ=90°
N^6^-furfuryladenine hydrochloride
C10H10N5O,Cl
Acta Crystallographica Section C (2003) 59, 1 o27-o29
a=4.5610(8)Å b=8.8980(17)Å c=13.562(3)Å
α=90° β=92.138(5)° γ=90°
<i>N</i>'-Hydroxypyrimidine-2-carboximidamide
C5H6N4O
Acta Crystallographica Section E (2014) 70, 10 o1107-o1108
a=7.4066(7)Å b=8.0165(8)Å c=10.2200(9)Å
α=90.00° β=101.888(6)° γ=90.00°